Real-time TMF oversight and collaboration with CROs
Single source of truth for eTMF
Digital inspection

As a sponsor, bringing your eTMF in-house and having your CROs work directly in your eTMF can provide long-term benefits, including more control over your data, better oversight, and continual digital inspection readiness in line with the latest EMA expectations.

Hear GW Pharmaceuticals’ experiences on the below topics:
  • The value of an in-house eTMF for better access, real-time control, and inspection readiness
  • How to avoid costly and high-risk end-of-study migrations and ensure compliance with GCP guidelines for digital inspections
  • CRO training and user access management
  • Rapid, cost-effective deployment options

More Customer Stories

Ora: Accelerating Trial Execution
How They Unified Processes
Daiichi Stays Inspection Ready With EDLs and Milestones
Staying Inspection Ready
GBT's Journey to Strategic TMF Management
Explore the Benefits

Interested in learning more about Veeva?